The LCR at the IKBKG Locus Is Prone to Recombine

American Journal of Human Genetics

Volumn 86, Issue 4, 2010, Pages 650-652

  Fusco, Francesca ^a   D'Urso, Michele ^a   Miano, Maria Giuseppina ^a   Ursini, Matilde Valeria ^a  

^a INSTITUTE OF GENETICS AND BIOPHYSICS ADRIANO BUZZATI TRAVERSO   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

GD11 GENE; GENE; GENE EXPRESSION; GENE FUNCTION; GENE LOCUS; GENE MUTATION; HUMAN; IKBKG GENE; LETTER; MENTAL DEFICIENCY; NUCLEOTIDE SEQUENCE; PHENOTYPE; PRIORITY JOURNAL; X CHROMOSOME;

CHROMOSOMES, HUMAN, X; FEMALE; GENE DOSAGE; GUANINE NUCLEOTIDE DISSOCIATION INHIBITORS; HUMANS; I-KAPPA B KINASE; LOCUS CONTROL REGION; MENTAL RETARDATION; MOTHERS; RECOMBINATION, GENETIC;

EID: 77950330289     PISSN: 00029297     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ajhg.2009.12.019     Document Type: Letter

References (18)

1. Vandewalle J., Van Esch H., Govaerts K., Verbeeck J., Zweier C., Madrigal I., Mila M., Pijkels E., Fernandez I., Kohlhase J., et al. Dosage-dependent severity of the phenotype in patients with mental retardation due to a recurrent copy-number gain at Xq28 mediated by an unusual recombination. Am. J. Hum. Genet. 85 (2009) 809-822
2. Sebban H., Yamaoka S., and Courtois G. Posttranslational modifications of NEMO and its partners in NF-kappaB signaling. Trends Cell Biol. 16 (2006) 569-577
3. Fusco F., Mercadante V., Miano M.G., and Ursini M.V. Multiple regulatory regions and tissue-specific transcription initiation mediate the expression of NEMO/IKKgamma gene. Gene 383 (2006) 99-107
4. Galgóczy P., Rosenthal A., and Platzer M. Human-mouse comparative sequence analysis of the NEMO gene reveals an alternative promoter within the neighboring G6PD gene. Gene 271 (2001) 93-98
5. van Loo G., De Lorenzi R., Schmidt H., Huth M., Mildner A., Schmidt-Supprian M., Lassmann H., Prinz M.R., and Pasparakis M. Inhibition of transcription factor NF-kappaB in the central nervous system ameliorates autoimmune encephalomyelitis in mice. Nat. Immunol. 7 (2006) 954-961
6. Gutierrez H., O'Keeffe G.W., Gavaldà N., Gallagher D., and Davies A.M. Nuclear factor kappa B signaling either stimulates or inhibits neurite growth depending on the phosphorylation status of p65/RelA. J. Neurosci. 28 (2008) 8246-8256
7. Philippe O., Rio M., Carioux A., Plaza J.M., Guigue P., Molinari F., Boddaert N., Bole-Feysot C., Nitschke P., Smahi A., et al. Combination of linkage mapping and microarray-expression analysis identifies NF-kappaB signaling defect as a cause of autosomal-recessive mental retardation. Am. J. Hum. Genet. 85 (2009) 903-908
8. Mochida G.H., Mahajnah M., Hill A.D., Basel-Vanagaite L., Gleason D., Hill R.S., Bodell A., Crosier M., Straussberg R., and Walsh C.A. A truncating mutation of TRAPPC9 is associated with autosomal-recessive intellectual disability and postnatal microcephaly. Am. J. Hum. Genet. 85 (2009) 897-902
9. Mir A., Kaufman L., Noor A., Motazacker M.M., Jamil T., Azam M., Kahrizi K., Rafiq M.A., Weksberg R., Nasr T., et al. Identification of mutations in TRAPPC9, which encodes the NIK- and IKK-beta-binding protein, in nonsyndromic autosomal-recessive mental retardation. Am. J. Hum. Genet. 85 (2009) 909-915
10. Fusco F., Bardaro T., Fimiani G., Mercadante V., Miano M.G., Falco G., Israël A., Courtois G., D'Urso M., and Ursini M.V. Molecular analysis of the genetic defect in a large cohort of IP patients and identification of novel NEMO mutations interfering with NF-kappaB activation. Hum. Mol. Genet. 13 (2004) 1763-1773
11. Hadj-Rabia S., Froidevaux D., Bodak N., Hamel-Teillac D., Smahi A., Touil Y., Fraitag S., de Prost Y., and Bodemer C. Clinical study of 40 cases of incontinentia pigmenti. Arch. Dermatol. 139 (2003) 1163-1170
12. Smahi A., Courtois G., Vabres P., Yamaoka S., Heuertz S., Munnich A., Israël A., Heiss N.S., Klauck S.M., Kioschis P., et al., The International Incontinentia Pigmenti (IP) Consortium. Genomic rearrangement in NEMO impairs NF-kappaB activation and is a cause of incontinentia pigmenti. Nature 405 (2000) 466-472
13. Sebban-Benin H., Pescatore A., Fusco F., Pascuale V., Gautheron J., Yamaoka S., Moncla A., Ursini M.V., and Courtois G. Identification of TRAF6-dependent NEMO polyubiquitination sites through analysis of a new NEMO mutation causing incontinentia pigmenti. Hum. Mol. Genet. 16 (2007) 2805-2815
14. Ropers H.H., and Hamel B.C. X-linked mental retardation. Nat. Rev. Genet. 6 (2005) 46-57
15. Aradhya S., Bardaro T., Galgóczy P., Yamagata T., Esposito T., Patlan H., Ciccodicola A., Munnich A., Kenwrick S., Platzer M., et al. Multiple pathogenic and benign genomic rearrangements occur at a 35 kb duplication involving the NEMO and LAGE2 genes. Hum. Mol. Genet. 10 (2001) 2557-2567
16. Fusco F., Paciolla M., Pescatore A., Lioi M.B., Ayuso C., Faravelli F., Gentile M., Zollino M., D'Urso M., Miano M.G., and Ursini M.V. Microdeletion/duplication at the Xq28 IP locus causes a de novo IKBKG/NEMO/IKKgamma exon4_10 deletion in families with Incontinentia Pigmenti. Hum. Mutat. 30 (2009) 1284-1291
17. Nelson D.L. NEMO, NFkappaB signaling and incontinentia pigmenti. Curr. Opin. Genet. Dev. 16 (2006) 282-288
18. Wong E.T., and Tergaonkar V. Roles of NF-kappaB in health and disease: Mechanisms and therapeutic potential. Clin. Sci. (Lond.) 116 (2009) 451-465